全文获取类型
收费全文 | 51112篇 |
免费 | 3771篇 |
国内免费 | 1270篇 |
专业分类
耳鼻咽喉 | 357篇 |
儿科学 | 962篇 |
妇产科学 | 1549篇 |
基础医学 | 4524篇 |
口腔科学 | 920篇 |
临床医学 | 5298篇 |
内科学 | 7913篇 |
皮肤病学 | 301篇 |
神经病学 | 2020篇 |
特种医学 | 1700篇 |
外国民族医学 | 9篇 |
外科学 | 4706篇 |
综合类 | 7438篇 |
现状与发展 | 1篇 |
预防医学 | 7270篇 |
眼科学 | 331篇 |
药学 | 5061篇 |
100篇 | |
中国医学 | 1758篇 |
肿瘤学 | 3935篇 |
出版年
2024年 | 71篇 |
2023年 | 711篇 |
2022年 | 1286篇 |
2021年 | 2234篇 |
2020年 | 2033篇 |
2019年 | 1813篇 |
2018年 | 1876篇 |
2017年 | 1713篇 |
2016年 | 1772篇 |
2015年 | 1751篇 |
2014年 | 3551篇 |
2013年 | 3545篇 |
2012年 | 3118篇 |
2011年 | 3397篇 |
2010年 | 2493篇 |
2009年 | 2419篇 |
2008年 | 2410篇 |
2007年 | 2485篇 |
2006年 | 1977篇 |
2005年 | 1749篇 |
2004年 | 1500篇 |
2003年 | 1229篇 |
2002年 | 1086篇 |
2001年 | 964篇 |
2000年 | 849篇 |
1999年 | 800篇 |
1998年 | 632篇 |
1997年 | 644篇 |
1996年 | 598篇 |
1995年 | 526篇 |
1994年 | 520篇 |
1993年 | 394篇 |
1992年 | 418篇 |
1991年 | 372篇 |
1990年 | 311篇 |
1989年 | 316篇 |
1988年 | 269篇 |
1987年 | 220篇 |
1986年 | 207篇 |
1985年 | 267篇 |
1984年 | 222篇 |
1983年 | 148篇 |
1982年 | 192篇 |
1981年 | 164篇 |
1980年 | 149篇 |
1979年 | 128篇 |
1978年 | 100篇 |
1977年 | 92篇 |
1976年 | 87篇 |
1975年 | 89篇 |
排序方式: 共有10000条查询结果,搜索用时 409 毫秒
101.
自制无针粉末注射给药系统药物导入率的体外评价 总被引:4,自引:3,他引:1
目的 建立体外吸收评价方法,考察自制无针粉末注射给药系统的给药性能。方法 以人体皮肤为研究材料,荧光素钠作为模型药物,高效液相-荧光法检测,以透皮吸收率为指标,采用正交试验设计优选无针粉末注射的载药喷射参数。结果 建立的方法分析时间小于3min,在0.2304-9.216ng范围内呈线性关系,绝对回收率大于99.8%,RSD〈0.8%;自制无针粉末注射给药系统的最高透皮吸收率可达到40%,超过普通透皮途经400倍以上,与国外同类产品的药物导入效率(33%)相当;正交试验分析表明气源压力、喷管型号、药物剂量、药粉粒径均对无针粉末注射的效果有影响。结论 建立的研究方法简便、快速、准确、可靠,可用于无针粉末注射系统的体外研究;自制无针粉末注射给药系统的药物导入效率较高,值得进一步推广应用。 相似文献
102.
103.
稳定性核素测定大鼠小肠蛋白质合成 总被引:2,自引:1,他引:1
目的:建立稳定性核素([L-^15N]亮氨酸)测定大鼠小肠蛋白质合成率的方法。方法:分别测定静脉注射相同剂量[L-^15N]亮氨酸不同时相的大鼠小肠^15N丰度及不同剂量[L-^15N]亮氨酸同一时相的大鼠小肠^15N丰度。结果:大鼠小肠游离氨基酸池中^15N核素丰度在注射后0.5h内呈线性上升并达高峰,维持4h后缓慢下降,小肠蛋白质中的^15N丰度0.5h至12h基本维持不变;随着注射剂量的增加,大鼠小肠蛋白质分数合成率(FSR)亦增加,当[L-^15N]亮氨酸剂量在1.0mmol/kg以上,FSR并不随施加[L15N]亮氨酸剂量的加大而增加。结论:在进行大鼠小肠蛋白质合成率测定时,一次性静脉注射的测量最佳时限为0.5h,剂量为1.0mmol/kg。 相似文献
104.
105.
X Dong M He X Song B Lu Y Yang S Zhang N Zhao L Zhou Y Li X Zhu R Hu 《Diabetic medicine》2007,24(12):1482-1486
AIMS: Our aim was to assess performances of the Cockcroft-Gault and simplified Modification of Diet in Renal Disease (MDRD) formulae in estimating glomerular filtration rate (GFR) in Chinese diabetic populations and their association with vascular risks. METHODS: A total of 1009 patients with Type 2 diabetes were categorized into low estimated GFR groups (GFR < 60 ml/min/1.73 m(2)) and control groups by the two equations. The performances of these formulae were assessed at different stages of kidney function. Carotid artery intima-media thickness (IMT) and the prevalence of diabetic retinopathy or albuminuria were compared among the groups. The ability of these formulae to identify established vascular risk markers using sensitivity, specificity, positive and negative predictive values were also compared. RESULTS: The prevalence of low estimated GFR was 32.7% with the Cockcroft-Gault formula and 5.2% with the MDRD formula, respectively. In low estimated GFR subjects by the MDRD formula, IMT was significantly thicker than those by the Cockcroft-Gault formula (1.2 mm vs. 1.0 mm; P < 0.05), with a higher prevalence of albuminuria (78.4 vs. 52.8%, P < 0.05) and diabetic retinopathy (46.5 vs. 30.5%; P < 0.05). The Cockcroft-Gault formula gave a specificity of 71.7% and a sensitivity of 37.0%, and the MDRD formula gave a specificity of 96.6% and a sensitivity of 7.9% in estimating low GFR relevant for established vascular risks. CONCLUSIONS: These formulae performed differently in Chinese diabetic populations. The simplified MDRD formula is minimally superior to the Cockcroft-Gault formula for its high specificity and positive predictive values in estimating low GFR relevant for vascular risks. 相似文献
106.
Yanli Song Dong Wang 《中国肿瘤临床(英文版)》2007,4(2):142-144
OBJECTIVE To investigate the effect of neoadjuvant chemotherapy in treatment of Stage Ⅱ breast cancer.
METHODS The data from 113 patients with breast cancer of the same pathologic type in Stage Ⅱ,during the period of 1995 to 2001,were analyzed retrospectively.Among the patients,47 were treated with neoadjuvant chemotherapy,and 66 received no adjuvant therapy before surgery(control group).After the patients of the neoadjuvant chemotherapy group had received 2 courses of chemotherapy with the CMF regimen,the surgical procedure was conducted.
RESULTS Complete remission(CR)was attained in 9 of the 47 cases receiving neoadjuvant chemotherapy and partial remission(PR)was reached for 22 cases.The rate of breast-conserving surgery was enhanced from 22.73%to 46.81%(P〈0.05)in the neoadjuvant treatment group.
There was no difference in the 5-year overall survival(OS)and disease-free survival(DFS)rate between the two groups(P〉0.05),but the 5-year OS and DFS of the cases with clinical tumor remission was higher compared to the control group(P〈0.05).
CONCLUSION Neoadjuvant chemotherapy can enhance the rate of breast conservation for Stage Ⅱ breast cancer and may improve the prognosis of the cases with clinical remission. 相似文献
107.
目的 研究甘肃棘豆生物碱部位对KM小鼠肝癌H22细胞抑制作用及其对KM小鼠免疫功能的影响。 方法 采用鼠源性肝癌细胞H22移植瘤法,将60只KM小鼠随机分为5组,其中高、中、低剂量组分别给予甘肃棘豆生物碱部位32、16、8 mg/kg体重灌胃,阴性对照组给予生理盐水(NS)20 mL/kg灌胃,5- 氟脲嘧啶(5-FU)组给予5-FU 15 mg/kg体重腹腔注射,每天1次,连续给药10天。检测平均瘤重和抑瘤率,计算脾指数、胸腺指数,MTT法测脾细胞增殖率。 结果 甘肃棘豆生物碱部位高、中、低剂量组对肝癌细胞H22实体移植瘤的抑制率分别为43%、29%、23%;各剂量组小鼠的脾指数和胸腺指数均明显高于阴性对照组,中、高剂量组明显高于5-FU 组(P<0.05);各剂量组在24、48、72 h的脾细胞增殖率也明显高于阴性对照组及5-FU 组(P<0.01)。 结论 甘肃棘豆生物碱部位对KM小鼠肝癌H22移植瘤有抑制作用,并能增强KM小鼠免疫功能。 相似文献
108.
Cholangiocarcinomas (CC) frequently demonstrate lymphatic spread. We investigated lymph node (LN) counts after resection of
extrahepatic CC and survival based on the SEER 1973–2004 database. Out of 20,068 CC patients, 1,518 individuals were selected
based on M0 stage and at least one LN examined. Primary cancer sites included gallbladder (29%), extrahepatic bile ducts (26%),
and intrapancreatic/ampullary bile ducts (45%); 42% of patients were LN-positive. The median number of LNs examined was four
(range 1–39). Median survival was 37 months for LN-negative and 16 months for LN-positive cancers. Multivariate prognostic
variables were the number of positive LNs, primary site, age (all at p < 0.0001), gender (p = 0.002), size (p = 0.005), T category (p = 0.009), and total LN count (or number of negative LNs obtained, p = 0.01). The impact of total LN counts was seen in LN-negative (median survival, 1 vs 10 or more LNs examined: 27 vs 51 months,
p = 0.002) and LN-positive disease (10 vs 22 months, p < 0.0001). Survival prediction of extrahepatic CCs is strongly influenced by total LN counts and numbers of negative LNs
obtained. Although the resulting incremental benefit is small, dissection and examination of 10 or more LNs should be considered
for curative intent resections. 相似文献
109.
Murat Hamit Aytar Fikret Doğulu Berker Cemil Ertan Ergün Gökhan Kurt Kemali Baykaner 《Child's nervous system》2007,23(6):719-721
Introduction Iniencephaly, a neural tube defect involving occiput and inion and combined with rachischisis of the cervical, thoracic spine,
and retroflexion position of the head is a very rare congenital abnormality of the fetus–newborn with a 0.1–10 of 10,000 prevalence.
This abnormality’s prognosis is thought to be dismal. This abnormality can be associated with other abnormalities such as
anencephaly, encephalocele, hydrocephalus, cyclopia, absence of the mandible, cleft lip and palate, cardiovascular disorders,
diaphragmatic hernia, renal abnormalities, overgrowth of the arms compared to the legs, and club food and gastrointestinal
atresia.
Discussion Most of the patients are dead born, and the others die in a few hours. There are only six previously documented long-term
survivors. In our case, our patient with iniencephalic signs and findings is still living. She is 2 years old now. We think
that this patient presents a mild form of iniencephaly. 相似文献
110.
目的观察散结抗瘤方对S180荷瘤小鼠的肿瘤抑制作用及其免疫调节作用。方法建立小鼠移植S180肉瘤模型。随机分为荷瘤对照组、环磷酰胺(CTX)组、散结抗瘤方组、散结抗瘤方加CTX组(联合组)。连续给药15 d后处死小鼠,计算其抑瘤率及胸腺和脾脏指数,并观察肿瘤组织的病理改变。结果荷瘤对照组的肿瘤生长迅速,散结抗瘤方组和CTX组肿瘤生长受到抑制(P均<0.05),而且二者合用时抑瘤效果更显著(P<0.01);与CTX组比较,散结抗瘤方组和联合组胸腺指数、脾脏指数均有提高。结论散结抗瘤方不仅可以抑制肿瘤生长,还对胸腺、脾脏有保护作用,具有良好的免疫调节作用。 相似文献